-ATPase, protein kinase C, cytochrome P450-dependent arachidonate metabolites, phosphatidylinositol-3-kinase
Na
+ ,K + -ATPase, located in the basolateral membranes of renal tubular cells, drives active Na + reabsorption throughout the nephron and is involved in the regulation of extracellular fluid volume and blood pressure. Na + ,K + -ATPase is regulated by numerous hormones and neuromediators, including dopamine, aldosterone, angiotensin II, nitric oxide and atrial natriuretic peptide . These mediators trigger several signalling pathways including cyclic nucleotide-dependent protein kinases, protein kinase C and arachidonate cascade. Protein kinase C (PKC) is a family of at least 10 related serine/threonine kinases divided into three groups. Classical or conventional PKCs (cPKCs) including PKCa, bI, bII and g, are activated by diacylglycerol (DAG), phorbol esters and calcium. Novel PKC isoforms (nPKCs), which include PKCd, PKCe, PKCh and PKCq, are also activated by DAG and phorbol esters but are Ca 2+ -independent. Finally, atypical PKCs (aPKCs), which include PKCz and PKCl, are not activated by either DAG or phorbol esters but may be regulated by other lipid mediators (Nishizuka, 1995; Ron & Kazanietz, 1999) . PKC is involved in the regulation of renal Na + ,K + -ATPase by dopamine, angiotensin II, endothelin I and norepinephrine . In vitro studies have revealed either stimulatory or inhibitory effect of PKC on renal Na + ,K + -ATPase depending on the nephron segment, experimental conditions and the method of enzyme assay . Recent studies indicate that the mechanisms regulating renal sodium pump are affected by multiple features of the microenvironment such as oxygen tension, pH, osmolality, calcium and sodium concentrations; all of them changing along the nephron (Kiroytscheva et al., 1999) . It is often impossible to adequately reproduce these complex biophysical conditions in vitro. Recently, we have developed an experimental model which allows study of the effect of hormones administered in vivo on renal Na + ,K + -ATPase. In this model, the investigated reagents are infused locally under anaesthesia and then the enzyme activity is assayed in the isolated microsomal fraction of the renal tissue. Using this model, we demonstrated that PKC-activating phorbol esters have a biphasic effect on renal cortical Na + ,K + -ATPase: low doses stimulate, whereas higher doses inhibit the enzyme activity (Bełtowski et al., 1998) . However, that study had several important limitations. First, phorbol esters are nonspecific activators of all classical and new PKC isoforms. Second, these compounds may induce PKC-independent effects (Ron & Kazanietz, 1999) . Although the observed changes were abolished by staurosporine, this inhibitor is not completely specific for PKC. Most importantly, however, the Na + ,K + -ATPase assay used in that study is not specific because the measured activity includes also ouabain-sensitive H + ,K + -ATPase (Bełtowski & Wójcicka, 2002) . Thus, the dose-dependent effect of phorbol esters could be accounted for, at least in part, by opposite regulation of both ouabain-sensitive enzymes.
More recently, we improved the specificity of our Na + ,K + -ATPase assay by adding a specific inhibitor of H + ,K + -ATPases, Sch 28080, to the incubation medium (Bełtowski & Wójcicka, 2002) .
In the present study, we reinvestigated the effect of PKC on renal cortical Na + ,K + -ATPase using this improved method. In addition, apart from phorbol esters, we used also PKC activators and inhibitors more specific toward different kinase isoforms. Finally, we wanted to get more insight into the mechanism of Na + ,K + -ATPase regulation by PKC. Experimental protocol. All studies were performed on adult male Wistar rats weighing 250-300 g. They had free access to food and water before the experiments. The animals were anaesthetized with pentobarbital (50 mg/kg, i.p.) and a thin catheter was inserted through the femoral artery into the abdominal aorta proximally (< 0.5 cm) to the renal arteries for infusion of the investigated substances. The position of the catheter was verified at the end of experiment. The study protocol was approved by the Bioethics Committee of the Medical University of Lublin.
After the surgery, infusion with physiological saline was started at the rate of 66 ml/min for 30 min (stabilization period). All investigated substances were infused as saline solution at the rate of 66 ml/min (4 ml/h). The total time of infusion was 60 min. Animals from the control group received 0.9% NaCl during the whole experiment. Each investigated compound was administered for 30 min, between 1 and 30 min or between 31 and 60 min of infusion. Until otherwise stated, PKC activators were administered between 31 and 60 min of infusion, whereas the compounds expected to block their effect -between 1 and 30 min. After the infusion, the abdominal cavity was opened and the aorta was ligated proximally to the end of the catheter. Then, 5 ml of 0.9% NaCl was infused within 1-2 min through the catheter to remove erythrocytes from the kidneys. The kidneys were excised and the animals sacrificed by a lethal dose of pentobarbital. Na + ,K + -ATPase activity was assayed in the microsomal fraction isolated from the renal cortex and medulla. The procedure of isolation was described in details previously (Bełtowski & Wójcicka, 2002 
where: v is actual enzyme activity, V max is maximal activity at saturating sodium concentration, [Na + ] is actual sodium concentration, K 0.5 is the dissociation constant for Na + measuring the affinity of Na + ,K + -ATPase for sodium, and n is Hill coefficient. In this model V max , K 0.5 and n were allowed to vary to obtain the best fit to the data. The effect of potassium concentration on Na + ,K + -ATPase was fitted to the following equation:
where v is the activity measured at a given potassium concentration [K + ], V max is the maximal activity and K 0.5 is the dissociation constant for K + . The following K + concentrations were used: 0.5, 1, 2, 5, 10 or 20 mM, supplemented to 20 mM with choline chloride. The effect of ATP on Na + ,K + -ATPase activity was studied by performing the assay in the presence of 0.1, 0.2, 0.5, 1, 2 or 3 mM ATP, and K 0.5 was calculated from the formula analogous to that used for potassium.
The inhibition of Na + ,K + -ATPase by ouabain was analyzed according to the following equation:
where v is the activity measured at a given concentration of the inhibitor [I], V max is the maximal activity and K i is the inhibition constant. Ouabain concentration was varied from 10 -7 to 10 -3 M in one-order steps. The kinetic parameters were calculated by nonlinear least squares regression separately for each animal and the values reported in Table 1 are means ± S.D. from 5 animals in each group. Statistics. Data are presented as mean ± S.D. from 8 animals in each group. Statistical analysis was performed by Student's t-test or analysis of variance (ANOVA) followed by Duncan's multiple range test, for comparison of 2 or > 2 groups, respectively. A P value < 0.05 was considered significant. Similarly to PDBu, PMA had no effect on medullary Na + ,K + -ATPase (not shown).
RESULTS

Effect of phorbol esters on renal cortical
In contrast to PDBu and PMA, 4a-phorbol didecanoate (4aPDD) which does not stimulate PKC, did not change cortical Na + ,K + -ATPase activity (not shown).
Because both PKC-activating phorbol esters caused similar effects, only PDBu was used in further studies. In addition, in subsequent experiments we used this compound only at two doses, 10 -11 and 10 -8 mol/kg per min, which induced maximal stimulation and inhibition of Na + ,K + -ATPase activity, and are therefore referred to as stimulatory and inhibitory doses, respectively.
Kinetic parameters of renal cortical Na + ,K + -ATPase
Because the results described above were obtained under V max conditions, in separate experiments we tested the effect of PDBu on kinetic parameters of this enzyme. As presented in Table 1 , both the stimulatory and the inhibitory effects of PDBu were characterized by significant changes in enzyme V max , whereas other kinetic parameters including K 0.5 for Na + , Hill coefficient, K 0.5 for K + , K 0.5 for ATP, and K i for ouabain were not affected. Therefore, all further studies were performed under V max conditions.
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Effect of PKC inhibitors
Both the stimulatory and the inhibitory effects of PDBu were abolished by pretreatment with PKC inhibitor, staurosporine (Fig. 2) . Staurosporine administered at a dose of 10 -9 mol/kg per min between 1 and 30 min of infusion had no effect on Na + ,K + -ATPase activity in control animals, however, pretreatment with staurosporine abolished the stimulatory effect of PDBu administered at a dose of 10 -11 mol/kg per min, as well as the inhibitory effect of 10 -8 mol/kg per min of PDBu. Because staurosporine is a nonspecific inhibitor of all PKC isoforms, we investigated the effect of three additional more specific inhibitors. GF109203X, which inhibits all classical and novel but not the atypical PKC isoforms, infused at a dose of 10 -8 mol/kg per min, prevented both the increase and the decrease of Na + ,K + -ATPase activity induced by PDBu (Fig. 2) . Gö 6976, which blocks all classical but not the novel or atypical PKC isoforms, administered at a dose of 10 -9 mol/kg per min also completely abolished the stimulatory and the inhibitory effect of PDBu on renal cortical Na + ,K + -ATPase. In contrast, LY333531, which is a specific inhibitor of PKCb, infused at a dose of 10 -8 mol/kg per min failed to block the effects of PDBu (Fig. 2) . GF109203X, Gö 6976 and LY 333531 had no effect on cortical Na + ,K + -ATPase if administered to animals which were not subsequently treated with PDBu.
Effect of thymeleatoxin on renal cortical Na + ,K + -ATPase
In subsequent studies we investigated the effect of another PKC activator, thymeleatoxin (THX), on renal cortical Na + ,K + -ATPase (Fig. 3) . THX is a diterpene derivative of mezerein which, unlike phorbol esters, stimulates only classical but not the novel PKC isoforms. THX administered at a dose of The animals received either 10 -11 or 10 -8 mol/kg per min PDBu between 31 and 60 min (white bars). In the separate groups, a non-specific PKC inhibitor, staurosporine (10 -9 mol/kg per min, grey bars), a specific inhibitor of classical and novel PKC isoforms, GF109203X (10 -8 mol/kg per min, batched bars), a specific inhibitor of classical PKC isoforms, Gö 6976 (10 -9 mol/kg per min, black bars), or a specific inhibitor of PKCb, LY333531 (10 -8 mol/kg per min, checked bars) was infused before PDBu. In rats not treated with PDBu, the PKC inhibitors were infused between 31 and 60 min. **P < 0.01; compared to control by ANOVA and Duncan's test. Recently, we (Bełtowski et al., 2003a) and others (Gonin et al., 2001; Vinciguerra et al., 2003) Recently, it has been demonstrated that the effect of PKC on renal Na + ,K + -ATPase is affected by intracellular Na + concentration;
PKC stimulates the sodium pump at low and inhibits at high intracellular Na + . To investigate whether the dose dependent switch of the effect of PDBu may be associated with its modulating influence on intracellular Na + , we examined interactions of this compound with reagents expected to affect apical sodium entry. Ethylisopropylamiloride (EIPA) selectively inhibits Na + /H + -exchanger -the major pathway of sodium entry into proximal tubule cells (Wang, 1997) . EIPA infused at a dose of 10 -6 mol/kg per min had no effect on Na + ,K + -ATPase stimulation by 10 -11 mol/kg per min PDBu. However, this dose of EIPA reversed the inhibitory effect of 10 -8 mol/kg per min PDBu (Fig. 5) (Table 2) . A similar effect was observed following administration of latrunculin B (0.5 mg/kg per min) which sequesters actin monomers and impairs the formation of actin filaments (Lamaze et al., 1997 Table 2) .
Neither of these PI3K inhibitors had any significant effect on cortical Na + ,K + -ATPase in control animals (not shown). An inactive analogue of LY 284002, LY303511, had no effect on Na + ,K + -ATPase inhibition by PDBu (Table 2).
DISCUSSION
The results of this study confirm our previous observation (Bełtowski et al., 1998) that PKC-activating phorbol esters have dose-dependent effects on renal cortical Na + ,K + -ATPase in the rat. Because in the present study Na + ,K + -ATPase was assayed in the presence of Sch 28080, the observed effect must be specific for Na + ,K + -ATPase and could not be accounted for by any changes in ouabain-sensitive H + ,K + -ATPase activity.
It is likely that phorbol esters elicit both effects by activating classical PKC isoforms, because their effect was blocked by Gö 6976 -a specific inhibitor of Ca 2+ -dependent PKC isoenzymes, and was mimicked by THX which is a specific activator of classical PKC isoforms. However, the involvement of PKCb should rather be excluded since LY 333531, a very selective inhibitor of PKCbI and bII (Ishi et al., 1996; Kowluru et al., 1998) , failed to prevent both the stimulatory and the inhibitory effect of PDBu. This is consistent with the results of numerous studies demonstrating that PKCbI and PKCbII are either absent or expressed at a very low level in the whole renal cortex and in tubule segments isolated from this region of the kidney (Ostlund et al., 1995; Karim et al., 1995; Wilborn & Schafer, 1996; Yao et al., 1998; Pfaff et al., 1999; Padanilam, 2001) . We cannot exclude the possibility that the stimulatory and the inhibitory effects of PDBu are mediated by distinct cPKC isoforms, e.g. a and g. However, it seems unlikely for several reasons. First, PDBu and PMA have similar affinity for these isoforms (Hofmann, 1997) and would be expected to stimulate both of them simultaneously rather than at so very different doses. Second, it is unlikely that all three activators (PMA, PDBu and THX) used by us have so similar dose-dependent effects on both PKC isoforms. Most importantly, PKCg is expressed in the kidney at a level much lower than PKCa. Activators and inhibitors with sufficient specificity toward PKCa and PKCg are not currently available and it was not possible to examine the individual involvement of these isoforms. However, the data presented above strongly suggest that the bidirectional effect of phorbol esters on cortical Na + ,K + -ATPase cannot be accounted for by differential effects of specific PKC isoforms, but is rather associated with the level of stimulation of a single isoform, presumably PKCa. creases the incorporation of pump molecules to the plasma membrane (Bełtowski et al., 2003a) . In contrast, the stimulatory effect of PKC was not affected by brefeldin A, indicating that redistribution of Na + ,K + -ATPase from the intracellular to the plasma membrane pool was not involved. The a 1 subunit of rat Na + ,K + -ATPase contains PKC phosphorylation sites at Ser16 and Ser21 ) and may be phosphorylated by this kinase in vitro and in intact cells (Bertorello et al., 1991; Feschenko & Sweadner, 1995; Logvinenko et al., 1996; Kazanietz et al., 2001) . Although some studies reported no change (Feschenko & Sweadner, 1995; or even a decrease (Bertorello & Aperia, 1989; Middleton et al., 1993; Belusa et al., 1997; Blanco et al., 1998; Kazanietz et al., 2001) in Na + ,K + -ATPase activity following PKC-dependent phosphorylation, this was observed mainly in an isolated enzyme preparation or in cells transfected with heterologous Na + ,K + -ATPase a 1 -subunit. In intact renal tubular cells, PKC-mediated phosphorylation correlates with an increase in Na + ,K + -ATPase activity (Feraille et al., 1995; Carranza et al., 1996; Pedemonte et al., 1997a; 1997b; Tsimaratos et al., 2003) . The a 1 subunit of Na + ,K + -ATPase may be dephosphorylated by protein phosphatases during tissue homogenization and protein phosphatase inhibitors added during preparation procedures increase the rate of enzyme phosphorylation (Nowicki et al., 1997) . In our experiments, okadaic acid added to the homogenization medium augmented the stimulatory effect of PKC on cortical Na + ,K + -ATPase. In contrast, cAMP-mediated stimulation was not affected by OA (unpublished observation), consistently with our hypothesis that cAMP induces redistribution of pump molecules to the plasma membrane (Bełtowski et al., 2003a) ; the process which is completed in vivo and could not be modified by the inhibition of phosphatases during tissue preparation. Also, the inhibitory effect of phorbol esters probably mediated by the internalization of Na + ,K + -ATPase (see below)
was not affected by OA in the present study. Taken together, these data suggest that PKC stimulates cortical Na + ,K + -ATPase by phosphorylating its catalytic subunit and modifying its catalytic properties. However, we can not exclude the possibility that PKC phosphorylates another protein which stimulates Na + ,K + -ATPase, such as the recently described regulatory g-subunit of this enzyme (Mahmmoud et al., 2000) . Recently, Tsimaratos et al. (2003) have demonstrated that PKCa phosphorylates Na + ,K + -ATPase a 1 -subunit and increases its V max without affecting Na + affinity or cell surface expression in rat medullary thick ascending limb. Although we studied the cortical enzyme and could not identify the PKC isoform involved, our results are consistent with their findings. In contrast, Feraille et al. (1995) have observed that PDBu increases Na + affinity of Na + ,K + -ATPase but has no effect on V max in isolated rat proximal tubule (PT) cells. The discrepancy between their and our results may be accounted for by several methodological differences. We administered PDBu in vivo and measured the Na + ,K + -ATPase activity in the whole cortex, which apart from PT contains also cortical thick ascending limbs, distal convoluted tubules and cortical collecting ducts. PKC could stimulate Na + ,K + -ATPase in these segments through different mechanisms. In addition, Feraille et al. (1995) were using smaller rats (130-150 g) than we did. Renal expression of specific PKC isoforms changes with age (Serlachius et al., 1997) , and different isoforms could have divergent effects on Na + ,K + -ATPase activity. In opossum kidney cells, phorbol esters increase Na + ,K + -ATPase activity by augmenting enzyme incorporation to the plasma membrane without affecting its turnover rate; this effect is mediated by PKCb (Efendiev et al., 1999; Budu et al., 2002) . As discussed earlier, it is unlikely that PKCb mediated the stimulatory effect of phorbol esters in our study. In addition, the recruitment of (Budu et al., 2002) , whereas in our study EIPA did not enhance the stimulatory effect of PDBu. Thus, the mechanism of Na + ,K + -ATPase stimulation by PKC differs depending on the experimental model, animal species, tubule segment studied and the PKC isoform involved.
Inhibitory effect of PKC
Several studies have demonstrated that PKC decreases Na + ,K + -ATPase activity in renal cells through a mechanism involving cytochrome P450-dependent arachidonate metabolites, in particular 20-HETE (Satoh et al., 1993; Ominato et al., 1996) . Subsequently, it has been suggested that this effect is observed only in hypooxygenated cells and is not physiologically relevant (Feraille et al., 1995; Kiroytscheva et al., 1999) . We have observed that protein kinase A (Bełtowski et al., 2003a) and G (Bełtowski et al., 2003b) decrease Na + ,K + -ATPase activity in the renal medulla in a 20-HETE dependent manner; the effect most likely accounted for by low oxygen tension in the medullary tissue. However, renal cortex has an adequate oxygen supply and it is unlikely that the inhibitory effect of PKC in the present study could be ascribed to hypoxic conditions. Efendiev et al. (2002) have demonstrated that the effect of PKC is determined by intracellular Na + concentration; PKC stimulates Na + ,K + -ATPase at low and inhibits at high intracellular Na + , the latter effect is mediated by 20-HETE. Sodium concentration in tubular cells is determined by apical passive entry and basolateral active transport by Na + ,K + -ATPase. PKC increases the activity of Na + /H + -exchanger -the major pathway of Na + entry into PT cells (Karim et al., 1999) . We hypothesized that higher doses of phorbol esters could stimulate apical sodium entry and increase intracellular Na + triggering cytochrome P450-dependent Na + ,K + -ATPase inhibition. Indeed, the inhibi- In vitro studies suggest that PKC and 20-HETE downregulate Na + ,K + -ATPase by causing its removal from the plasma membrane through clathrin-coated vesicles (CCV) to early and late endosomes (Chibalin et al., 1997; 1998a; 1998b; 
